David DAndrea
Overview
Explore the profile of David DAndrea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
191
Citations
1610
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scilipoti P, Longoni M, de Angelis M, Zaurito P, Slusarczyk A, Soria F, et al.
BJU Int
. 2025 Feb;
PMID: 39967051
Objective: To assess the oncological outcomes of patients with high-risk (HR) and very high-risk (VHR) non-muscle-invasive bladder cancer (NMIBC) treated with upfront radical cystectomy (RC) vs Bacillus Calmette-Guérin (BCG) instillations...
2.
Gallioli A, Uleri A, Verri P, Tedde A, Mertens L, Moschini M, et al.
Eur Urol Focus
. 2025 Feb;
PMID: 39894734
Background And Objective: Data about the mid- and long-term oncologic outcomes of endoscopic kidney-sparing surgery (eKSS) for upper tract urothelial carcinoma (UTUC) are scarce. Therefore, we aimed to summarize the...
3.
Cadenar A, Mancon S, Shariat S, DAndrea D
Curr Opin Urol
. 2025 Jan;
35(2):189-193.
PMID: 39820224
Purpose Of Review: This review explores the potential role of neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) for oligometastatic bladder cancer (OMBC) treatment. We focused on extrapolating evidence from...
4.
DAndrea D, Mostafid H, Gontero P, Shariat S, Kamat A, Masson-Lecomte A, et al.
Eur Urol Oncol
. 2024 Nov;
8(1):216-229.
PMID: 39550339
Background And Objective: Non-muscle-invasive bladder cancer (NMIBC) poses a significant clinical challenge, particularly when failing bacillus Calmette-Guérin (BCG) therapy, necessitating alternative treatments. Despite radical cystectomy being the recommended treatment, many...
5.
6.
Basile G, Uleri A, Leni R, Cannoletta D, Afferi L, Baboudjian M, et al.
Eur Urol Oncol
. 2024 Oct;
PMID: 39428278
Background And Objective: En bloc resection of bladder tumor (ERBT) has been introduced to enhance the quality of resection of bladder cancer. This review aims to compare the perioperative and...
7.
Liu K, Nicoletti R, Zhao H, Chen X, Wu H, Leung C, et al.
World J Urol
. 2024 Sep;
42(1):547.
PMID: 39331198
Objective: To investigate the impact of ageing on survival outcomes in Bacillus Calmette-Guérin (BCG) treated non-muscle invasive bladder cancer (NMIBC) patients and its synergy with adequate BCG treatment. Method: Patients...
8.
Katayama S, Pradere B, Grossman N, Potretzke A, Boorjian S, Ghoreifi A, et al.
J Endourol
. 2024 Sep;
38(11):1156-1163.
PMID: 39264866
Although previous literature shows tumor location as a prognostic factor in upper tract urothelial carcinoma (UTUC), there remains uninvestigated regarding the impact of tumor location on grade concordance and discrepancies...
9.
Klager J, Koeller M, Oszwald A, Wasinger G, DAndrea D, Comperat E
Virchows Arch
. 2024 Sep;
PMID: 39222123
Substaging of T1 urothelial cancer is associated with tumor progression and its reporting is recommended by international guidelines. However, it has not been integrated in risk stratification tools and there...
10.
Mancon S, Soria F, Pradere B, DAndrea D
Eur Urol
. 2024 Jul;
86(5):481-482.
PMID: 39054191
No abstract available.